Toxoplasma gondii genotyping in 2,467 human toxoplasmosis cases from France and other geographical origins: genetic diversity and clinical associations
Abstract
Background Toxoplasma gondii exhibits marked variation in genetic diversity, yet the relationships between parasite genotype and clinical presentation in humans remain poorly understood. We investigated the diversity of T. gondii strains infecting humans and their associations with different forms of toxoplasmosis. Methodology/Principal Findings We retrospectively analyzed 2,467 T. gondii-positive human clinical cases collected in France through a nationwide network of hospital parasitology diagnostic units over more than four decades. Cases included patients receiving care in mainland France, including residents, travelers, and immigrants, as well as patients managed in French overseas territories in South America, the Indian Ocean, and Oceania. Parasite genotyping was performed using a standardized panel of 15 microsatellite markers. Complete genotypes were obtained for 1,269 cases, revealing 13 distinct genetic groups, including clonal lineages and non-clonal populations, alongside genotypes that could not be assigned to any recognized group. Type II strains predominated overall (82.6%) and were particularly frequent in congenital toxoplasmosis (869/955 cases, 91.0%). Despite being predominantly associated with infraclinical or mild congenital infections, type II strains were also responsible for severe congenital infections following maternal infection during all three trimesters of pregnancy, as well as acquired ocular toxoplasmosis. Haplogroup 16, encompassing strains previously assigned to multiple PCR-RFLP genotypes, showed an association with severe congenital toxoplasmosis, with six of seven cases presenting severe manifestations. Type I strains were remarkably rare (n = 5) and showed no signs of increased clinical severity compared to type II. Amazonian strains, another genetically diverse group, were identified almost exclusively in acquired toxoplasmosis in immunocompetent patients, all of them severe, in keeping with previous reports of the exceptional pathogenicity of this genetic group. In immunodeficient patients, Africa 1 strains (equivalent to ToxoDB#6) were more frequently associated with isolated cerebral toxoplasmosis (20/25 cases, 80%) than type II and type III strains. Overall, the results support that while a given T. gondii genetic group may be associated with a broad spectrum of clinical manifestations, significant differences in disease presentation exist between genetic groups. Conclusions/Significance This study constitutes the largest collection of human T. gondii genotypes linked to clinical data assembled to date and provides new insights, at a global level, into the relationships between parasite genetic diversity and clinical manifestations of toxoplasmosis. Our findings suggest a role for parasite genotype in shaping disease presentation, even in the context of strong host-related determinants such as immunodeficiency or gestational timing of infection. These results also highlight the value of long-term surveillance networks for understanding the epidemiology and pathogenicity of T. gondii on a global scale.
Related
- Associations of Dietary Inflammatory Potential, Dietary Diversity, and Micronutrient Adequacy with Rheumatoid Arthritis: A Case–Control Study from India
- Case Report: Severe persistent transaminitis during pregnancy: a complex differential diagnosis involving suspected toxoplasmosis, possible drug-induced liver injury, and intrahepatic cholestasis
- Associations of dietary diversity with depressive symptoms, anxiety symptoms and their co-occurrence among reproductive-age women in three low- and middle-income countries: a cross-sectional analysis
- Cross-sectional study on norovirus genotyping and epidemiology among hospitalised children with acute gastroenteritis in Tianjin, North China, 2020–2023
- Guided P2Y12 inhibitor selection after rapid CYP2C19 genotyping in patients undergoing percutaneous coronary intervention
BibTeX
@misc{herault2026toxoplasma,
title = {{Toxoplasma gondii genotyping in 2,467 human toxoplasmosis cases from France and other geographical origins: genetic diversity and clinical associations}},
author = {E. Herault and M. Vergonjeanne and K. Passebosc-Faure and T. Gelle and M.-F. Durieux and F. Boumediene and J.-B. Murat and R. A. Lavergne and F. Gay-Andrieu and N. Dahane and J. Fillaux and F. Touafek and L. Paris and M.-P. Brenier-Pinchart and C. Garnaud and M. Leveque and Y. Sterkers and C. Pomares and N. Ferret and F. Robert-Gangneux and H. Guegan and D. Filisetti and O. Villard and A. S. Deleplancque and F. Dalle and C. L Ollivier and J. Bonhomme and B. Langlois and N. Van Langendonck and C. Hoffmann and G. Gargala and I. Accoceberry and J. Guitard and M. Wallon and E. Perraud and S. Houze and A. Totet and C. Damiani and C. Nourrisson and E. Scherer and F Grenouillet},
howpublished = {medRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.26.26366474},
url = {https://www.medrxiv.org/content/10.64898/2026.10.26.26366474v1},
note = {CC BY-NC},
}
RIS
TY - UNPB
TI - Toxoplasma gondii genotyping in 2,467 human toxoplasmosis cases from France and other geographical origins: genetic diversity and clinical associations
AU - E. Herault
AU - M. Vergonjeanne
AU - K. Passebosc-Faure
AU - T. Gelle
AU - M.-F. Durieux
AU - F. Boumediene
AU - J.-B. Murat
AU - R. A. Lavergne
AU - F. Gay-Andrieu
AU - N. Dahane
AU - J. Fillaux
AU - F. Touafek
AU - L. Paris
AU - M.-P. Brenier-Pinchart
AU - C. Garnaud
AU - M. Leveque
AU - Y. Sterkers
AU - C. Pomares
AU - N. Ferret
AU - F. Robert-Gangneux
AU - H. Guegan
AU - D. Filisetti
AU - O. Villard
AU - A. S. Deleplancque
AU - F. Dalle
AU - C. L Ollivier
AU - J. Bonhomme
AU - B. Langlois
AU - N. Van Langendonck
AU - C. Hoffmann
AU - G. Gargala
AU - I. Accoceberry
AU - J. Guitard
AU - M. Wallon
AU - E. Perraud
AU - S. Houze
AU - A. Totet
AU - C. Damiani
AU - C. Nourrisson
AU - E. Scherer
AU - F Grenouillet
PY - 2026
DA - 2026/10/26
PB - medRxiv
DO - 10.64898/2026.10.26.26366474
UR - https://www.medrxiv.org/content/10.64898/2026.10.26.26366474v1
AB - Background Toxoplasma gondii exhibits marked variation in genetic diversity, yet the relationships between parasite genotype and clinical presentation in humans remain poorly understood. We investigated the diversity of T. gondii strains infecting humans and their associations with different forms of toxoplasmosis. Methodology/Principal Findings We retrospectively analyzed 2,467 T. gondii-positive human clinical cases collected in France through a nationwide network of hospital parasitology diagnostic units over more than four decades. Cases included patients receiving care in mainland France, including residents, travelers, and immigrants, as well as patients managed in French overseas territories in South America, the Indian Ocean, and Oceania. Parasite genotyping was performed using a standardized panel of 15 microsatellite markers. Complete genotypes were obtained for 1,269 cases, revealing 13 distinct genetic groups, including clonal lineages and non-clonal populations, alongside genotypes that could not be assigned to any recognized group. Type II strains predominated overall (82.6%) and were particularly frequent in congenital toxoplasmosis (869/955 cases, 91.0%). Despite being predominantly associated with infraclinical or mild congenital infections, type II strains were also responsible for severe congenital infections following maternal infection during all three trimesters of pregnancy, as well as acquired ocular toxoplasmosis. Haplogroup 16, encompassing strains previously assigned to multiple PCR-RFLP genotypes, showed an association with severe congenital toxoplasmosis, with six of seven cases presenting severe manifestations. Type I strains were remarkably rare (n = 5) and showed no signs of increased clinical severity compared to type II. Amazonian strains, another genetically diverse group, were identified almost exclusively in acquired toxoplasmosis in immunocompetent patients, all of them severe, in keeping with previous reports of the exceptional pathogenicity of this genetic group. In immunodeficient patients, Africa 1 strains (equivalent to ToxoDB#6) were more frequently associated with isolated cerebral toxoplasmosis (20/25 cases, 80%) than type II and type III strains. Overall, the results support that while a given T. gondii genetic group may be associated with a broad spectrum of clinical manifestations, significant differences in disease presentation exist between genetic groups. Conclusions/Significance This study constitutes the largest collection of human T. gondii genotypes linked to clinical data assembled to date and provides new insights, at a global level, into the relationships between parasite genetic diversity and clinical manifestations of toxoplasmosis. Our findings suggest a role for parasite genotype in shaping disease presentation, even in the context of strong host-related determinants such as immunodeficiency or gestational timing of infection. These results also highlight the value of long-term surveillance networks for understanding the epidemiology and pathogenicity of T. gondii on a global scale.
ER -